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Pre-Publication Draft 
Tracing the Shifting Sands of ‘Medical Genetics’: 
What’s in a Name? 
Abstract:  This paper focuses on the structural development of institution-based interest 
in genetics in Anglo-North American medicine after 1930 concomitantly with an analysis 
of the changes through which ideas about heredity and the hereditary transmission of 
diseases in families have passed. It maintains that the unfolding relationship between 
medicine and genetics can best be understood against the background of the shift in 
emphasis in conceptualisations of recurring patterns of disease in families from 
‘biological relatedness’ to ‘related to chromosomes and genes.’ The paper begins with 
brief considerations of the historical confluences of, first, heredity and medicine and, 
second, genetics and medicine which, in a third section, leads to a discussion about a 
uniquely ‘genetics-based approach’ to medicine in the second half of the twentieth-
century. 
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1. Introduction 
The term ‘medical genetics’ first appears in Lancelot Hogben’s book ‘Genetic Principles 
in Medicine and Social Science’ (1931): ‘Whatever views one may entertain concerning 
the urgency of social policies based on genetic assumptions, the urgency of promptitude 
in developing the machinery of research in medical genetics should not be overlooked by 
any who have the advancement of pure science at heart.’1 The term does not appear again 
in the book, but I feel confident in saying that ‘Genetic Principles in Medicine and Social 
Science’ was the source of inspiration for Madge Thurlow Macklin’s writings on the 
subject of medical genetics. 2 Whilst Macklin neither cites nor references Hogben in her 
work, she clearly shared a perceived need to, as Hogben put it, ‘infiltrate the curriculum 
of clinical studies’ with instruction in human genetics. 3 Moreover, Hogben’s enthusiasm 
for promoting genetics as ‘an exact science’4 and the future potential of ‘chromosome 
maps’5 both appear as themes in Macklin’s work.  
It is fair to say that Macklin was much more tenacious and proactive than Hogben 
in her campaigns for human genetics instruction in medicine. 6 At the Third International 
Eugenics Congress held during August 1932, she declared: 
I feel very much like Ulysses when he was steering between Scylla and Charybdis, 
for on the one hand there is the non-medical advocate of eugenics who may resent 
my emphasis upon the medical practitioner as the pivotal point in the eugenic 
programme, and on the other there is the medical practitioner who may object to 
my suggestion that he needs more education upon the subject of heredity as 
applied to medicine. My course, though difficult, is nevertheless clear. 7   
 
Genetics, she asserted, is ‘… a young science, and that genetics applied to medicine is a 
mere infant. But it is a very lusty one and will keep on crying until it is heard.’ 8 
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Macklin went on to write a series of articles on the subject which culminated in 
1933 with a sample syllabus for a course in medical genetics. In addition, she produced a 
massive review article on the role heredity plays in clinical phenomena in which she 
provides an impressive list of 200 heritable diseases and discusses twin studies, 
consanguineous marriage, family pedigrees, and statistical techniques. 9 Macklin 
reasoned that attending to the hereditary components of diagnosis made possible early 
detection, diagnosis, and commencement of therapies, and was therefore important in 
terms of preventive medicine. Further to this, being a strong supporter of eugenics, she 
believed that ‘the triumphs of modern preventive medicine’ had served to ‘throw into 
stronger relief the problems of human inheritance;’  
… persons spared from death by infection are kept alive to succumb to their 
constitutional disorders, so that we find the death rate from many of the 
degenerative disorders of the circulatory system, from cancer and from diabetes, 
rising. 10 
 
These ideas all provided grounds for supporting Hogben’s entreaty for scientific 
investigations of the physical basis of inheritance and for teamwork ‘on a very large 
scale’ involving the collaboration of geneticists, clinicians, and ethnologists to ‘assess the 
relative importance of nature and nurture in a specified range of conditions’ including 
‘such physical characteristics as growth limits and resistance to disease.’ 11 That being 
said, the contemporary historian Daniel Kevles has shown that fewer than two hundred 
people published any research in the early Anglo-North American contingent of human 
geneticists prior to the Second World War. 12 Of these, fewer than fifty published more 
than once. The situation changed noticeably after the Second World War.  
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Formal positions for human geneticists had been created in thirty-one centres in 
the United States (twenty-five), Canada (four), and England (two) by the end of the 
1950s.13 Comparatively speaking, five surveys, completed over a period of three decades, 
show that the proportion of North American medical schools with formal courses in 
genetics increased from 8.6 per cent in 1953 to 86.5 per cent in 1985.14  Correspondingly, 
across the Atlantic, the membership lists of the Genetical Society of Great Britain show a 
sharp increase in members involved in medical research in the UK after 1959, rising 
steeply to 1969 when nearly 12 per cent of the 900 members of the Society were working 
in medicine.15 The eventual growth and recognition of medical genetics as a service 
specialism in the UK and North America that occurred after 1970 came about largely as a 
result of technological innovations in the form of, first, the new laboratory technologies 
for identifying chromosomal anomalies and genetic metabolic disease, and, second, the 
advent of regional newborn screening programs and increased use of amniocentesis in 
prenatal diagnosis. In all of these countries, the intellectual and specialist movements that 
supported this growth were emergent phenomena, created, split, and reattached to 
different groups of actors, and reconfigured at least twice over the next four decades. In 
each instance, new kinds of working relationships appeared; sets of diverse actors in 
university-hospital settings coalesced into a new collectivity; and, as a collectivity, actors 
defined and/or redefined occupational roles and work rules. In the first instance, an elite 
of PhD- and MD-geneticists built career paths through their work in newly established 
clinical settings for heredity counselling. These individuals established specialised work 
patterns by combining hospital work and teaching posts. Furthermore, they drew a 
 5 
clientele of patients on the basis of personal reputations for specialised expertise. In the 
second instance, counselling and laboratory services became standardised and specialised 
occupational roles and work rules for clinical and laboratory services were established. In 
the translatory movement from medical segment to medical specialty, the ideological 
direction of clinical practices conformed to a pattern widely adopted among 
contemporary medical specialties. As a result, a formal job classification – medical 
geneticist – became viable as a full-time occupation in medicine in the UK and North 
America. 
This paper focuses on the structural development of institution-based interest in 
genetics in Anglo-North American medicine after 1930 concomitantly with an analysis of 
the changes through which ideas about heredity and the hereditary transmission of 
diseases in families have passed. Taking into consideration the lag between theoretical 
and therapeutic capability in the application of new scientific knowledge, I argue that the 
unfolding relationship between medicine and genetics can best be understood against the 
background of the shift in emphasis in conceptualisations of recurring patterns of disease 
in families from ‘biological relatedness’ to ‘related to chromosomes and genes.’ I 
understand the shift in emphasis to represent a bringing together of the organisational 
ideas of key innovators in science and medicine and I explore the corresponding 
characteristics of the institutions they built.  I do not claim that the changes in 
conceptualisations represent average ‘medical thinking’ at the time; they did not. A 
minority built academic specialty was formed intending to train a new generation of 
medical specialists in order to reform clinical practice. Accordingly, a key aim of this 
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paper is intended to permit identification of what objects, questions, concepts, methods, 
and research are properly considered medical and the institutional steps through which a 
‘genetics-based approach’ to medicine became distinguishable and duly recognised. 
2. The historical confluences of heredity and medicine 
Historians of medicine studying the topic of heredity normally posit an early or pre-
modern period in which stories were collected about so-called monstrous births in the 
naturalist tradition of sixteenth-century Europe.16 What is most noteworthy here, for the 
purposes of the present study, is the movement from the singularity of legends, anecdotes, 
and story-telling to the generality of systems of taxonomy supported by case studies that 
were published and archived.17 Case studies of morbid haereditarii (heritable disease) 
recount a range and categories of physical/developmental forms as well as biographical 
aspects of illness episodes or narratives in time. As particular ‘clues’ and ‘symptoms’ 
took on special roles and significance (e.g., missing or supernumerary limbs, birth marks 
diminished stature) case studies took on emblematic status.18 At the same time, the notion 
of the ‘familial taint’ lent typicality to the case at hand. The physician became ‘a 
chronicler of bodily events and systematic narrator of particular phenomena in a 
particular context.’19 Case studies in turn supported natural history and the seeking out of 
nosological categories for classifications of disease.  
Historians Laure Cartron and Carlos López-Beltrán suggest that physicians and 
physiologists in eighteenth-century France were the first to use the word heredity 
(hérédité) to refer to the phenomenology of peculiar character or trait transmission from 
parents to offspring.20 Cartron specifically links the ideas of hereditary disposition to 
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disease, predisposing diathesis (i.e., an acquired susceptibility of the body to disease), 
and constitutional weakness (i.e., inherent weakness in the physical make-up of a 
person).21 This supplements earlier work by Erwin Ackerknecht who showed that the 
notion of diathesis gained popularity in medical circles at the end of the eighteenth 
century and ‘constitution studies’ flourished in the United States, France, and Germany 
by the 1920s.22 At the same time, Ackerknecht indicates interest in these topics was 
waning and being ‘outdistanced by bacteriology, endocrinology, serology, vitaminology, 
the neurology of the vegetative system, or genetics’ by the 1940s. Indeed, Antonio 
Ciocco, in his 1936 paper on the ‘modern study of constitution,’ complained about the 
apparent growing disregard of the ‘so-called genetic school of constitutionalists’ for the 
field constitutional somatology.23 As late as 1943, George Draper, an associate professor 
of clinical medicine at Columbia University, sought support for constitutional medicine 
and recognition of the biological significance of the human constitution from the 
standpoint of a ‘school of biological thought known as “organicist” or “organical,” as 
opposed to the [school of] elementalist or particulate [thought of geneticists].’ 24 Draper 
claimed that the modern physician ‘labours in the anthropological division of biology’ 
and that although the basic sciences of physics and chemistry had provided explanations 
of certain physiological phenomena found in the clinic, there still remained a number of 
vital phenomena in need of explanation ‘related to the whole organism’ including ‘the 
phenomena of heredity, growth, and development.’25 Likewise, Julius Bauer, then 
professor of clinical medicine at College of Medical Evangelists, Los Angeles, observed: 
It is taken for granted – usually without particular amazement – that the potential 
energy of the germ plasm accounts for the development of a full-fledged human 
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being out of a fertilized human ovum of microscopic proportions in the short 
period of nine months. It is not adequately realized, however, that this potential 
energy is at work throughout a whole lifetime; that the physiologic evolution and 
involution, the structure and function of the organs, their mutual relation, and the 
response to various stimuli depend on this potential energy; that deficiencies and 
abnormalities of this potential energy may be cooperative etiologic factors or the 
sole cause of diseases; that they account for the vast majority of congenital 
malformations in man. And this potential energy is just what we may call 
individual constitution. The great miracle of this potential energy is fully 
recognized as far as the fetal development is concerned, but the miracle is not 
over with the moment of birth. 26 
 
Bauer had emigrated via France to the United States after the German annexation 
of Austria in 1938. 27 Bauer hoped that constitutional medicine could be connected to 
current work being done in the United States with breeding and experimental genetics. 28 
At the same time, he acknowledged a certain weakness in such an idea: 
One point … should be stressed: constitution is not a physical entity but a panel 
and plan of the total set-up of the individual personality. Constitution comprises 
physical and mental traits, visible and invisible characteristics, which may or may 
not be detectable by all or any of the various methods of physical examination and 
laboratory work. Constitution is therefore not a measurable entity; but some of its 
components may be defined in exact figures. 29 
 
The weakness was not lost on critics of constitutional medicine.  
A reviewer of the book, ‘Human Constitution in Clinical Medicine’ (1944), 
described what he called a ‘subtle defeatism’ in constitutional medicine that viewed 
disease as an ‘inevitable product’ in certain susceptible individuals’ and an ‘undercurrent 
of therapeutic pessimism.’ 30 This, he argued, represented an ‘anachronism’ in modern 
medicine. While interest in the human constitution was subsequently taken up and 
advanced by some psychologists and physical anthropologists interested in constitutional 
somatotyping, genetics came to occupy an increasingly important position in the clinical 
study of heredity as a result of a scientific line of inquiry that confined investigations to a 
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few specific problems associated with the transmission of physical characteristics 
between generations. 31 More specifically, Mendelian research on aspects of factoral 
transmission, sexual reproduction, and the production of physical variation in organisms 
served to limit the scope of biological inquiry and departed significantly from earlier 
programmes of research to explain the links between heredity, embryonic development 
and evolution. 32 
3. The historical confluences of genetics and medicine 
Archibald Garrod’s work on ‘inborn errors of metabolism’ is a likely place to look for 
early connections between genetics and medicine. 33 Garrod had developed an interest in 
chemical pathology while working as a physician on the staff of several hospitals in 
London in the late nineteenth- and early twentieth-centuries.34 After being appointed as 
an assistant physician to the outpatients department of the Hospital for Sick Children in 
Great Ormond Street, he began to write about cases of rare disorders such as alkaptonuria 
and porphyrinuria which produce different colours in urine. Garrod’s initial observations 
led him to focus on chemical errors in the metabolism which appear as congenital defects 
that persist throughout life. 35 He went on to interpret the recurrence patterns in families 
as following Mendel’s law of recessive inheritance.36 For this he received advice and the 
collegial approbation of William Bateson, an early proponent of Mendelian genetics and 
founder of the Genetical Society of Great Britain, and Frederick Gowland Hopkins, a 
chemist who, in 1894, graduated in medicine and taught for four years physiology and 
toxicology at Guy’s Hospital before moving on to Cambridge University.37 Still, although 
the links between defective enzymes, disruptions in metabolic pathways, and disease 
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were evident in the contemporary biochemical literature, biochemists were generally 
unfamiliar with the tenets of Mendel’s laws. Equally, geneticists and physicians were 
unable to link the idea of a genetically-based enzyme deficiency to any concept of genes 
or of gene action. 38  
It is important to note that while Garrod was intrigued by the discovery of the 
metabolic disease phenylketonuria in the 1930s, the association between the disease and 
genetics was made by others. 39 Moreover, there is evidence that Garrod was more 
interested in the holistic line of inquiry found in constitutional studies. Pauline Mazumdar, 
for example, has found that his reconfiguration of the theory of diathesis under the notion 
of ‘chemical individuality’ was ‘constructed within the guidelines set by the German 
clinicians who formed a group round Friedrich Martius, professor in Rostock, Wilhelm 
His, Friedrich Kraus, and Otto Lubarsch in Berlin, and Julius Bauer in Vienna.’40  That 
being said, J. B. S. Haldane’s research on the genetics of flower coloration of the 1920s 
and 1930s at the John Innes Institutions and Sewall Wright’s studies of melanin in animal 
coats of the early 1940s were important to the geneticisation of Garrod’s theories.41 And, 
in the mid-1930s, Beadle and Ephrussi took Garrod’s ideas further and, using grafting 
experiments, sketched the steps and genetics that lead to the eye color of Drosophila 
melanogaster (i.e., the fruit fly). This demonstrated the sequential chain of events in a 
normal metabolic chain and contributed significantly to Beadle and Tatum’s ‘one gene, 
one enzyme’ hypothesis which stated that the function of a gene is to direct the formation 
of a particular enzyme. Garrod’s term ‘inborn errors of metabolism’ was subsequently 
changed in the 1950s to ‘metabolic disorders’ and came to refer to what affects the ability 
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of a cell to perform biochemical reactions that involve the processing or transport of 
proteins (amino acids), carbohydrates (sugars and starches), or lipids (fatty acids). In sum, 
Haldane, Beadle, Ephrussi, and Tatum reconfigured Garrod’s ideas in a manner that 
gradually informed a picture of how genetic information is converted to specified 
sequences of proteins with enzymatic function. Each of the steps involved in the 
problem-shift surrounding metabolic disorders was made within the context of the search 
for specific causes to chemical disturbances, and each additional step expanded the 
original clinical research program. This line of thinking, in turn, laid the conceptual 
groundwork for devising testing procedures and technologies for the detection and 
quantification of soluble metabolites in urine and blood after 1930. 
A second connection between genetics and medicine can be seen to develop as 
increasing numbers of researchers working in the fields of morphology, embryology, and 
cytology set about looking for abnormalities in chromosomal structures in order to 
establish correspondences between structure and hereditary effect. As early as 1901, the 
pathologist J. George Adami had proposed a physical model for inheritance based on the 
‘fortuitous comingling’ of chromatin during sexual reproduction.42 Various particulate 
theories of heredity followed based on ideas about the relations between Mendelian 
‘factors’ (later called genes) and characteristics and traits in living organisms. Hugo de 
Vries and William Bateson each had ideas about ‘unit characters’ that connected with 
‘factors.’ 43 An attempt to use genetic theory to explain heredity in terms of chromosomal 
events also appears in W. F. R. Weldon’s lectures on heredity at University College 
London as early as 1904. 44 But it was the work of Thomas Hunt Morgan and colleagues 
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at Columbia University that consolidated the chromosomal theory of heredity in Anglo-
North American science after 1915 and encouraged ongoing research which sought to 
localise hereditary materials within the chromosome.45  
The association of sex-determination with a chromosomal element had been 
suggested in the early 1890s with Hermann Henking and colleagues in Germany 
reporting an unpaired ‘chromatin-element’ that did not pair with the others during 
meiosis in the wasp Pyrrhocoris. Henking noted that the male wasps possess twenty-
three chromosomes. Twenty-two of these were observed as active in eleven pairs during 
spermatogenesis; the twenty-third remained unpaired.46 Moreover the behaviour of the 
‘odd’ element was different with respect to movement during cell divisions. But Henking 
did not go on to identify this element as a chromosome. It was the American cytologist 
and palaeontologist Clarence E. McClung and his student, Walter S. Sutton, who 
observed similar uneven pairings in the grasshopper Xiphidium in 1899 and named the 
element the ‘accessory chromosome.’47 Sutton, following the work of the German 
cytologist Theodor Heinrich Boveri, went on to develop definitive arguments concerning 
the association and orderly behaviour of paternal and maternal chromosomes as 
constituting the physical basis of the Mendel’s laws of inheritance.48 The chromosome 
theory as expounded by Boveri and Sutton provided a framework for others who sought 
to localise hereditary elements in the nucleus of the cell. Briefly, Boveri and Sutton 
proposed that, first, chromosomes retain their individuality from one cell division to 
another; second, the developing egg obtains corresponding chromosome sets from egg 
and sperm nuclei; and, third, each of these parental sets, separately, is sufficient for 
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normal development of the ‘germ,’ i.e., hereditary essence. Given that these three 
hypotheses identify the chromosomes as carriers of hereditary substance, two divergent 
possibilities presented themselves. Each chromosome might contain the total hereditary 
substance or that each chromosome may be the carrier of different portions of the 
hereditary elements. In the latter case, each chromosome would be of different genetic 
value. 
In 1911, the American embryologist Thomas Hunt Morgan, studying the 
determination of sex and the hereditary transmission of mutations in Drosophila 
melanogaster, coined the phrase ‘sex-limited inheritance’ and associated it with a specific 
chromosome. 49 This work led, in 1915, to the publication of The Mechanism of 
Mendelian Heredity, which Morgan coauthored with Alfred Henry Sturtevant, Hermann 
Joseph Muller, and Calvin Bridges. Importantly, when these authors turned to the 
chromosome as the epistemic object of study they did not attempt to subsume 
embryological concerns about the physiological capabilities of the egg or embryo under a 
particulate model. Rather, they segregated questions of development and the role of the 
cytoplasmic-organisational context in realizing the acquisition of hereditary characters.50 
This instigated a dichotomous view of the organism and what Ron Amundson has called 
‘the cleavage between heredity and development.’ 51 The concept of heredity 
consequently ‘narrowed’ and the interpretation of phenotypic events such as hereditary 
disease could then be pursued in relation to the study of a hypothetical entity called a 
gene. Morgan, in this context, managed to lay the conceptual foundation for ongoing 
research on the physical location of genes on chromosomes in which heredity appeared as 
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a background assumption of a formal system of genetic operations. He dubbed this 
research ‘transmission genetics’ which he distinguished as different from ‘developmental 
genetics’ which was to be pursued in relation to experimental embryological studies.52 
Alongside this conceptual foundation, the material object of the chromosome was 
embedded within associated laboratory practices in the fields of cytology and microscopy 
which would prove invaluable to laboratory medicine.53   
Research on human chromosomes did not progress as quickly as work on 
relatively simple organisms like Drosophila melanogaster for reasons of serious technical 
problems in the preparation and examination of tissues under microscopic examination.54  
But by the mid-1930s, chromosomes could be recognised individually through their 
shapes and bands and, by the late-1930s, examination materials prepared with colchicines 
allowed researchers to spread out and tease the individual chromosomes apart. 55 The 
process was refined in the 1950s and the precise number of the human ‘karyotype’ was 
established as 46 chromosomes. Advances in karyotype analysis in the 1950s permitted 
some types of major chromosomal abnormalities, including missing or extra copies of a 
chromosome or gross breaks and rejoinings (i.e., translocations), to be detected by 
microscopic examination. And, by the late 1950s, the syndromes of Down, Turner, and 
Klinefelter were correctly karyotyped and women with triple-X identified, establishing a 
basis for what later became known as ‘cytogenetics’ in laboratory medicine. A standard 
system of nomenclature for human mitotic chromosomes in medicine followed in 1960.56 
The classificatory system, in turn, facilitated greater cooperation between laboratory 
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scientists in France, Sweden, Japan, North America, and the UK, as well as enhancing the 
diagnostic potential of cytogenetics in laboratory medicine. 
It is important here to stress the novelty of human cytogenetics and biochemical 
analysis during the postwar period. Chromosomal and biochemical analyses provided the 
first clinical tools to uncover the genetical element of certain rare and common heritable 
disorders. At the same time, it is important to understand that the impact of these 
innovations on clinical practice evolved slowly, with disparity and divisions in how the 
individuals involved thought about themselves and the ways they characterised their 
activities. 
4. A genetics-based approach to medicine 
A 1954 Association of American Medical Colleges report represents the first concerted 
effort to produce a blueprint for the future of genetics in medicine.57 On a high level of 
generality, its discussions of an ‘integrated curriculum’ and a role for geneticists in 
medical schools remain faithful to what Lancelot Hogben and Madge Thurlow Macklin 
had originally proposed in the 1930s. First of all, methods involving the identification of 
hereditary factors in disease are described in the report as supplementing the practices of 
‘any [medical] specialty that can be named’.58 Second, and concurrently, ‘genetics ... 
serves as a useful tool in the prevention of disease and limitation of disability’.59 Turning 
to the question of what to teach, the report recommends five fundamental areas of study 
for consideration: the physical basis for heredity; the basic single gene mechanisms; 
interaction between heredity and environment; mutation and its evolutionary 
significance; knowledge of population genetics as well as instruction in the practice of 
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genetic counselling. The authors suggest that these fundamentals can be covered 
adequately in twelve to fourteen hours of lectures, ‘if supplemented by a moderate 
amount of reading in available texts’ – less than half what Macklin had envisioned as a 
thirty-six hour lecture course. 60  
Turning to the question of who should teach, participants in the workshop 
generally agreed upon ‘a trained medical geneticist on the staff.’ 
He might be either an M.D. with special training in genetics, or a Ph.D. in human 
genetics with added training in the special applications of his subject to medical 
problems. Such a person could be attached to any department in accord with 
administrative convenience. He could function in several ways: he might teach the 
course or give the lectures on general principles in the second year. He could be 
used for integrated teaching in many areas, as for example in the problems of 
maternal-fetal immunologic incompatibilities, in connection with the teaching of 
metabolic diseases, anaemia, bone and eye diseases and in other areas.61 
 
The medical geneticist ‘could also have service and research functions.’62 Thus, a multi-
faceted role was envisioned. As ‘staff geneticist’ in a teaching hospital setting would 
provide advisory services, on the one hand, in family counselling directly with 
consultants, and, on the other, to practitioners and researchers requiring consultation in 
cases involving complex genetic problems. 
Importantly, there was a wholesale shift in the way genetic counselling was to be 
conducted and certain irreconcilable differences identified between the ameliorism of the 
eugenic ‘heredity consciousness’ and ‘preventive ideas of medicine’ advocated by 
Hogben and Macklin and what was being presented as value-free science in the postwar 
period. 63   This shift would find its expression most forcefully in what Sheldon C. Reed, 
director of the Dight Institute of Human Genetics, called ‘non-directive genetic 
counseling;’ a procedure intended to explain to patients ‘what the genetic situation is … 
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but the decision must be a personal one between the husband and wife, and theirs 
alone.’64 Reed explained: 
Counseling in medical genetics is a most important practical application of the 
findings of the science of human genetics. It could help almost every family if 
available to them. We are still in the beginning stages of the development of 
sound practices in genetic counselling. As long as we do not take ourselves too 
seriously but instead approach the problems in a light-hearted manner, there will 
be no danger of the gory excesses committed in the name of eugenics in the past. 
… 
… It is the physician who is likely to have a hand in shaping the future 
evolution of mankind because our reproduction is no longer completely 
capricious. The desire for a happy family of normal children is one of the 
strongest human motivations. For the first time in history the physician is able to 
be of major assistance in achieving the highest of life’s goals. If a couple finds 
that the family is increasing beyond their fondest expectations, he can slow down 
the flood. In civilized countries responsible parents no longer leave reproduction 
to the vagaries of chance. The physician officiates at the birth of the child and is 
the authoritative source of scientific information about reproduction.65 
 
In this context, non-directive genetic counselling, in effect, was to become a contract for 
services and the essence of the physician-patient relationship would be transformed from 
one of status to one of contract. 66  
The recommendations of the 1954 AAMC report enjoyed considerable support 
and further discussion in subsequent surveys and reviews. Three surveys indicate that, 
rather than an integrated curriculum, genetics instruction increasingly became the 
preserve of paediatricians and geneticists teaching in independent genetics departments. 67 
This issue went on to be described in the surveys and reviews as an interdisciplinary 
‘problem;’ a problem frustrating the larger goal ‘that “genetically thinking” becomes an 
integral part of [all] medical practice.’68 From this emerged what I have called elsewhere 
a bifurcated ideological construct69 that shaped and informed the means of organising a 
‘genetics-based approach’ to medicine.70 The construct stipulated, on the one hand, that 
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the mandate of medical genetics was to add a new set of medical procedures to the 
clinical repertoire of all individuals trained as physicians. On the other hand, it indicated 
that when and where physicians were unable to provide the new procedures, a class of 
specialists (i.e., medical geneticists) would be available for consultation. Accordingly, 
Vincent M. Riccardi, Baylor College of Medicine, stressed: 
... it is incumbent on clinicians in all health care disciplines to recognize when 
health impairment is due, in part or in whole, to a genetic cause. All clinicians 
must be able to determine whether a given disorder is genetic, possibly genetic, or 
not genetic, and be able to share that information with the patient or family and 
refer them, if necessary, to specialists for further assistance. ... 
Ensuring that a family with a genetic disorder receives genetic counselling 
is a primary care responsibility, even though the actual genetic counselling may 
be carried out by a specialist in a secondary or tertiary care facility. 71 (Emphasis 
in the original) 
 
It is certainly the case that local associative strategies among medical 
professionals surrounding specialty formation and the institutionalisation of genetics-
based diagnostic and laboratory services initially emphasised, on the one hand, 
multidisciplinary task specialisation among service providers working in regional centres 
and, on the other, more or less continually unfolding internal differentiation among 
academic health centres, community clinics, consumer and voluntary groups, government 
agencies, and public health departments. The patterned and the temporal organisation of 
contemporary genetic health services in the UK and North America nevertheless reflects 
different levels of interplay between autonomous action and constraining structure in 
local settings. On the one hand, geneticists entering clinical settings learned to conduct 
themselves in accordance with the same proscriptions that stem from the diverse histories 
of service relationships at the particular institutions employing them. Still, geneticists 
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also maintain that, as medical specialists, they provided services in a manner that is 
similar, if not the same, as others in their specialism around the world. Accordingly, it is 
important, from an historical standpoint, to distinguish between what are here ideal-
typically the features of medical genetics in toto and factors affecting the way that 
specialty services have been delivered locally.  
The addition of the new laboratory services for identifying chromosomal 
anomalies and genetic metabolic disease described in the previous section of this paper 
contributed significantly to the growth of counselling clinics which, during the 1950s, 
had developed in an ad hoc and piecemeal fashion.72 These technological innovations 
combined with the organisation of regional newborn screening programs in the 1960s and 
increased use of amniocentesis in prenatal diagnosis in the 1970s meant that genetics 
consultants experienced an increase in demand for services and, consequently, an 
increase in workload. As a result, concerted measures were taken to not only secure more 
resources and expansion for existing services, but to elevate the level and quality of 
services across, on the one hand, provincial and state genetics centres in Canada and the 
United States and, on the other, National Health Service regions in the UK. 
With the increase in demand for genetic services, one can see the sequence of 
associative movements, segmentalisation, and other aspects inherent in the process of 
specialty formation typically found in sociological accounts of medical specialties.73 In 
all cases, geneticists offering counselling and laboratory services found themselves 
spending proportionally less time in academia and research, and more time worrying 
about what was going on in the clinics. More pointedly, geneticists who provided 
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counselling and laboratory services in the late 1960s became more self-conscious about 
their patterns of work in professional medicine. Increasingly, two key questions were 
raised in professional circles: How does medical genetics fit into the delivery of patient 
care? How do geneticists as medical specialists incorporate other specialists and non-
medical personnel into their own schemes of work and aspiration? Both of these 
questions, in time, found expression in an assortment of concrete efforts to establish some 
kind of formal mechanism to create and maintain standards for the delivery of genetic 
services at the national level. 
Canada was among the first nations to develop standards of service and training 
overseen and administered by a body of medical professionals: The Canadian College of 
Medical Geneticists. 74 The College, established in 1976, preceded similar developments 
in the Netherlands, the United States, Finland, Sweden, Germany, France, and Denmark. 
The Canadian case shows how occupational specialisation in the broader field of genetics 
and medicine underwent remarkable divarication in a relatively short period of time. 
Moreover, it shows that the role of the geneticist in medicine evolved to a point where 
interchangeability between clinical- and laboratory-based functions abated.  
Medical genetics in the UK took a more circuitous route. Broadly speaking, the 
formal structure for the National Health Service ‘integrated genetics service’ fit well 
within the regimes of service delivery instituted between 1974 and 1982 when the NHS 
was reorganised to integrate hospital, community health care and family practitioner 
services under a unified management structure. By 1982, genetic laboratory services and 
counselling clinics were to be found in nineteen NHS regions across the UK. 75 The 
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regional genetic centre became the hallmark of British medical genetics, holding regular 
clinics in the centre and also satellite clinics to which clinicians would be dispatched to 
see patients in District General Hospitals. A decade later, responsibility for genetic 
services would devolve from regional administration to conurbations of districts. 
The notion of the regional genetics centre that emerged from the 1970s and 1980s 
combined ideas about the health needs of populations with an omnibus ‘genetic 
approach’ to health and illness. In its simplest geographical aspect, regional services 
consisted of two generalised unit parts: the centre and the adjoining catchment area. The 
two developed together, each presupposing the other. But while the centre was compact 
and readily visible, the catchment area was diffuse and difficult of precise observation. 
The boundaries of regional genetic services in fact appeared in varying degrees of 
distinctness at the local level according to the repertoire of policy instruments available, 
the preferences of the dominant technocratic elites, and the position and power of local 
bureaucracies to control funding and other kinds of resources. Genetic services, in this 
context, represent a series of concentric zones around service centres which differ in the 
degree of attachment of their occupants to the centres, of the frequency of movement of 
patients or patient information to and from the centres, and in the extent to which contacts 
with the centres are, on the one hand, direct, involving the movement of individuals, or, 
on the other, indirect, involving a circulation of information and specimens rather than 
people.  
With regard to the division of labour in the delivery of services in regional 
genetics centres in both the UK and North America, two broad sets of activities can be 
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discerned that involved the geneticist in the capacity of consultant. The first set falls 
under a general category of prenatal care in pregnancy and childbirth, and overlaps with 
the jurisdictional claims of obstetrics and gynaecology. This set of activities can be 
distinguished from ‘general genetics,’ which is a catch-all category for clinical activities 
involving infants, children and adults. As a set of activities unto itself, it can be further 
divided into three sub-sets. Activities in the first sub-set overlap with the jurisdictional 
claims of neonatology. This involves the diagnosis and management of congenital 
anomalies and diseases in newborns. The second sub-set takes up broader paediatric 
concerns and focuses on the diagnosis and management of genetic conditions in children.  
Finally, the third sub-set deals with, on the one hand, the diagnosis of adult-onset 
diseases and, on the other, screening for carriers of heritable conditions. In this regard, 
the character of the jurisdictional interface with other specialists (i.e., non-geneticists) 
shifts paradigmatically depending on whether the patient is a pregnant woman, an infant, 
a child, or an adult. 
It is especially noteworthy that open competition between clinical geneticists and 
other specialists for jurisdiction over particular kinds of patients and types of disease has 
gone virtually unheard of. 76 By the turn of the century, clinical interest in applied human 
genetics expanded to embrace a wider set of service relations as progressively more 
physicians and allied health personnel from specialty areas other than medical genetics 
either took over the diagnosis and management of patients in independent clinics or 
worked jointly with genetic service providers in hybridised clinical units for specific 
illness groups characterised as ‘complex,’ ‘multifactorial’ or ‘polygenic.’ This would 
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normally be seen from historical and sociological viewpoints as evidence of competing 
specialist segments and jurisdictional disputes in medicine, i.e., as an encroachment on 
the medical geneticists’ claim to professional jurisdiction over a genetics-based 
approached to medicine.77 Correspondingly, a late twentieth-century analysis of primary 
medical specialties might expect an ideological shift on the part of medical genetics in the 
direction of de-specialisation in order to accommodate the expanding remit of the 
genetics-based approach in medicine and changes in the administration of health services 
marked by deregulation and a transition away from centralised styles of governance. 78 
But service providers in genetic health services themselves have not seen the situation in 
this way. Generally speaking, they see other specialists as coming around to their way of 
thinking. 79 
Interjurisdictional relationships between specialists have been negotiated in a 
manner reminiscent of what the American sociologist Anselm Strauss called ‘silent 
bargains’ and ‘implicit negotiation.’80 Strauss made a distinction here between 
‘transactions openly carried out between parties who recognise their own negotiating’ 
and negotiations that are ‘implicit, their products being tacit agreements or 
understandings;’ 
… the main issue is ... that actions are being taken with respect to non-negotiated 
limits imposed or signalled by one side and agreed to directly by the other. These 
kinds of silent bargains, then, would seem to pertain to agreements that are not 
much brought into explicit discussion and that represent limits within which 
negotiation can go on. Sometimes .... they go on in support of the limits, or they 
temporarily stretch the limits.81 (Emphasis in original) 
 
An argument follows that goes something like this: In the first place, the 
jurisdictional interface between medical genetics and other specialties has been 
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reinforced and strengthened by innovations and routines in applied human genetics. 
Networked innovation and the circulation of standards of laboratory and clinical practice 
(i.e., the genetics-based approach to medicine) can be seen to have diffused horizontally 
across a large number of specialty areas, as its advantages apply in different clinical 
settings and service activities. As awareness of the genetics-based approach to medicine 
increases, collegial recognition of the expert role of the geneticist among medical 
specialties is reinforced and fortified. Medical genetics is therefore inclusive as opposed 
to exclusive in the occupational hub culture of medicine. 
In both the UK and North America, diagnostic tests and counselling for numerous 
illness groups became universally available in the 1980s through networks of regional 
genetic health services, although the availability of the full range of tests varied from 
centre-to-centre. All centres had access to laboratories for chromosome analysis (i.e., 
cytogenetics) and biochemical analysis for metabolic disorders. The delivery of 
laboratory services in genetics centres fell under the budget of a laboratory services 
department administered by pathology departments or divisions of medical genetics. In 
the case of infrequent testing for rare diseases, the costs would be absorbed into the 
budgets of researchers studying the specific conditions in question populations. Payment 
for the counselling services, however, was different owing to the vagaries of the 
provincial fee schedules in Canada and health market costings in the United States. Under 
the NHS, steps were taken to centralise six service components – genetic assessment, 
clinical diagnosis, cytogenetic analysis, biochemical diagnosis, prenatal genetic diagnosis, 
and case management involving genetic counselling – to be funded with global budgets 
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with the understanding that a portion of funding be allocated to satellite clinic 
programming.  
It was the introduction of DNA testing regimes in the mid-1980s that sets into 
relief major differences in the UK and North America with respect to the position and 
power of local bureaucracies to influence growth in medical genetics. Whilst I have 
already commented in the previous section of this paper on the importance of 
advancements in biochemical and chromosomal analyses for specialty formation, I have 
not thus far said anything about the so-called ‘molecular revolution.’ Use of the term 
‘new genetics’ in the medico-scientific literature appeared sometime around 1979 with 
reports and comments in medical journals concerning applications of recombinant DNA 
techniques, and new approaches to mapping and determining the fine structure of the 
human genome.82  The terms ‘molecular genetics’ and ‘molecular geneticist’ appeared 
soon thereafter. 83  
Early acknowledgement of the clinical potential for DNA testing techniques by 
British geneticists is evident in two reports issued by two working parties of the Clinical 
Genetics Society in the early 1980s 84 and in a joint Department of Health and MRC 
initiative started in 1984 to assess recombinant DNA technology in relation to existing 
genetic services at Manchester, London, and Cardiff. 85  The evaluation included 
recommendations from the Health Service Research Unit at St Thomas’s Hospital, 
London for the establishment of a strong centralised bureaucracy at the national level to 
oversee the existing network of regional DNA laboratories. 86 None of the regional 
genetics centres provided the full range of tests available. Moreover, there was no 
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strategic overview to ensure the availability of effective testing services and to avoid 
unnecessary duplication of service provision. The differences between testing facilities 
were made up for largely by informal inter-centre service arrangements largely sustained 
by local interests. DNA testing had not become routine by this time, automation and kit-
based technologies had yet to make a major impact on laboratory work. Most of the raw 
materials needed to do testing (e.g., DNA probes, restriction enzymes and gels for 
electrophoresis) could all be made in the laboratory, and with no expensive 
instrumentation, set-up costs for laboratories were low. There was, nonetheless, constant 
change and shifting ground within the technology of molecular diagnostics which meant 
that laboratory staff had to remain on top of advancements in basic research. 87 
British policymakers went on to outline steps to regulate the administration of 
genetic diagnostic tests and formalise inter-centre service arrangements on a national 
level for laboratories throughout the UK. The regulation of genetic testing began with the 
establishment of the Advisory Committee on Genetic Testing in 1996. The mandate of 
the Committee was to establish efficacy and product information requirements to be met 
by manufacturers and suppliers of genetic tests. The Committee was subsumed into the 
Human Genetics Commission in 1999 which began a public consultation on the future of 
testing regulation in 2002. 88 A 2003 White Paper, Our Inheritance, Our Future, 
subsequently outlined a commitment on the part of government of more than £18 million 
to upgrade NHS genetics laboratory facilities and £3.5 million to increase the workforce 
in the laboratories. 89 Consequently, two National Genetics Reference Laboratories were 
set up at Manchester and Salisbury to research and evaluate new technologies and ways 
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of testing, offer training, disseminate information on best practice, and expand existing 
quality assurance programs.  
6. Conclusions 
When we consider ‘medical genetics’ as a historical subject, we find that its 
distinctiveness from other medical specialisms is a matter for debate and we do not seem 
to be dealing with a single set of techniques and methods. The story of medical genetics 
is therefore not a linear history of ideas, although ideas are at its centre. One can note a 
reductionist manoeuvre to unify and subsume (i.e., reduce), on the one hand, all that has 
been observed in clinical accounts of episodes of familial illness and, on the other, all that 
has been observed about cells, chromosomes, genes, proteins, and enzymes in genetic 
science, in order to explain processes and structures talked about in complex higher-order 
theories concerning the aetiology of hereditary diseases. The conceptualisation of 
‘hereditary disease’ as a unique entity, like the common tendency in medicine to segment 
ailments of the body according to organ sites, has opened up new vistas of clinical 
research and practice, which, in turn, have justified the study of human genetics as a 
matter of serious concern for clinicians. 
This paper shows that there were stages of consensus reached about a particular 
approach claimed as fundamental for knowledge about hereditary disease. Implicit in this 
discussion is an assumption that successful monitoring of patterns and rates of disease is 
the result of technological advances in science and medicine. Chromosomal and 
biochemical analyses provided the first clinical tools to uncover and determine the 
genetical element of certain heritable diseases. Correspondingly, the essence of the 
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physician-patient relationship in genetic counselling would be transformed from one of 
status to one of contract. New kinds of working relationships appeared with the growth 
and development of medical genetics as a service specialism. Sets of diverse actors in 
university-hospital settings coalesced into a new collectivity; and, as a collectivity, actors 
defined and/or redefined occupational roles and work rules.  
Initially, an elite of geneticists built career paths through their work in newly 
established clinical settings for genetic health services. These individuals established 
specialised work patterns by combining hospital work and teaching posts. They drew a 
clientele of patients on the basis of personal reputations for specialised expertise in a 
manner that recalls what Victor Thompson described as ‘personal specialisation.’ 90 
Specialist status arose from the person, and not the task. Using Thompson’s 
nomenclature, there was high personal specialization in the medical genetics prior to 
specialty formation, but only one operative role, i.e., the geneticist in the teaching 
hospital setting. In the translatory movement from medical segment to medical specialty, 
the ideological direction of clinical practices conformed to a pattern widely adopted 
among contemporary medical specialties. As a result, a formal job classification – 
medical or clinical geneticist – became viable as a full-time occupation in medicine. 
‘Task specialisation’ followed with counselling and laboratory services becoming 
standardised and specialised occupational roles and work rules for clinical and laboratory 
services being institutionalised across networks of regional genetic service centres in the 
1970s.  
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As a final point, the paper indicates that, of late, networked innovation and the 
circulation of standards of laboratory and clinical practice are diffusing horizontally 
across a wide variety of specialty areas as the advantages the genetics-based approach are 
applied in different clinical settings and specialist activities other than medical genetics. 
This, I would like to suggest, represents a new development in what I have described as a 
bifurcated ideological construct that has shaped and informed the means of organising a 
genetics-based approach to medicine. The construct stipulates, on the one hand, that the 
mandate of medical genetics is to add a new set of medical procedures to the clinical 
repertoire of all health service providers. On the other hand, the mandate also provides 
for a class of specialists (i.e., medical geneticists) who will be available for consultation 
and assistance to other health service providers in pursuit of offering a genetics-based 
approach to medicine. The new development reinforces the idea that medical genetics is 
inclusive as opposed to exclusive in the occupational hub culture of medicine.
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